Oxford BioDynamics Plc (AIM: OBD)
London
· Delayed Price · Currency is GBP · Price in GBX4.445
+0.145 (3.37%)
Sep 11, 2024, 4:21 PM GMT+1
Oxford BioDynamics Income Statement
Financials in millions GBP. Fiscal year is October - September.
Millions GBP. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
| Revenue | 0.62 | 0.51 | 0.15 | 0.34 | 0.46 | 0.91 | Upgrade
|
| Revenue Growth (YoY) | 113.49% | 231.17% | -54.84% | -25.22% | -49.72% | -23.52% | Upgrade
|
| Cost of Revenue | 0.36 | 0.24 | 0.04 | - | - | - | Upgrade
|
| Gross Profit | 0.26 | 0.27 | 0.12 | 0.34 | 0.46 | 0.91 | Upgrade
|
| Selling, General & Admin | 9.96 | 8.81 | 6.94 | 5.62 | 4.07 | 3.54 | Upgrade
|
| Research & Development | 0.8 | 0.76 | 0.53 | 0.9 | 0.62 | 0.47 | Upgrade
|
| Other Operating Expenses | -1.03 | -0.83 | -0.35 | -0 | -0 | -0.04 | Upgrade
|
| Operating Expenses | 11.66 | 10.43 | 8.72 | 7.85 | 5.41 | 4.63 | Upgrade
|
| Operating Income | -11.4 | -10.17 | -8.6 | -7.51 | -4.95 | -3.72 | Upgrade
|
| Interest Expense | -0.24 | -0.21 | -0.2 | -0.11 | -0.02 | - | Upgrade
|
| Interest & Investment Income | 0.05 | 0.07 | 0.01 | 0.03 | 0.12 | 0.2 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -0.04 | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.03 | 0.03 | 0.12 | -0.03 | -0.06 | 0.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | -1.25 | 1.1 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -11.53 | -11.52 | -7.57 | -7.63 | -4.95 | -3.39 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0 | 0.11 | - | - | - | - | Upgrade
|
| Pretax Income | -11.53 | -11.41 | -7.57 | -7.63 | -4.95 | -3.39 | Upgrade
|
| Income Tax Expense | -0.43 | -0.59 | -0.86 | -0.95 | -0.6 | -0.59 | Upgrade
|
| Net Income | -11.11 | -10.83 | -6.71 | -6.68 | -4.35 | -2.8 | Upgrade
|
| Net Income to Common | -11.11 | -10.83 | -6.71 | -6.68 | -4.35 | -2.8 | Upgrade
|
| Shares Outstanding (Basic) | 179 | 147 | 100 | 93 | 93 | 93 | Upgrade
|
| Shares Outstanding (Diluted) | 179 | 147 | 100 | 93 | 93 | 93 | Upgrade
|
| Shares Change (YoY) | 49.58% | 47.92% | 7.72% | - | 0.00% | 5.51% | Upgrade
|
| EPS (Basic) | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.07 | -0.07 | -0.07 | -0.05 | -0.03 | Upgrade
|
| Free Cash Flow | -6.77 | -8.54 | -5.54 | -8.61 | -3.51 | -2.67 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.06 | -0.06 | -0.09 | -0.04 | -0.03 | Upgrade
|
| Gross Margin | 41.49% | 52.16% | 75.32% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -1848.14% | -1993.73% | -5585.06% | -2202.93% | -1085.75% | -410.47% | Upgrade
|
| Profit Margin | -1800.32% | -2122.75% | -4357.14% | -1959.53% | -953.73% | -308.71% | Upgrade
|
| Free Cash Flow Margin | -1096.60% | -1675.29% | -3597.40% | -2525.22% | -769.30% | -294.49% | Upgrade
|
| EBITDA | -10.74 | -9.51 | -8 | -6.86 | -4.63 | -3.34 | Upgrade
|
| D&A For EBITDA | 0.67 | 0.66 | 0.61 | 0.65 | 0.32 | 0.39 | Upgrade
|
| EBIT | -11.4 | -10.17 | -8.6 | -7.51 | -4.95 | -3.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.